Yaky Yanay
2019
In 2019, Yaky Yanay earned a total compensation of $887K as Chief Executive Officer at Pluristem Therapeutics, a 100% increase compared to previous year.
Compensation breakdown
| Salary | $396,632 |
|---|---|
| Stock Awards | $461,100 |
| Other | $29,253 |
| Total | $886,985 |
Yanay received $461.1K in stock awards, accounting for 52% of the total pay in 2019.
Yanay also received $396.6K in salary and $29.3K in other compensation.
Rankings
In 2019, Yaky Yanay's compensation ranked 9,814th out of 13,971 executives tracked by ExecPay. In other words, Yanay earned more than 29.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,814 out of 13,971 | 30th |
Division Manufacturing | 3,960 out of 5,701 | 31st |
Major group Chemicals And Allied Products | 1,509 out of 2,200 | 31st |
Industry group Drugs | 1,291 out of 1,886 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 287 out of 389 | 26th |
Source: SEC filing on May 20, 2020.
Yanay's colleagues
We found three more compensation records of executives who worked with Yaky Yanay at Pluristem Therapeutics in 2019.
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019